Pioneering Cancer Treatment: CAR-T & NK Cell Therapy in Beijing, China
Beijing Gobroad Boren Hospital in China provides advanced CAR-T and NK Cell Therapy for lymphoma, leukemia, and multiple myeloma.
Beijing Gobroad Boren Hospital, a distinguished member of the PlacidWay global medical tourism network, stands as a premier oncology center in Beijing, China. This facility specializes in advanced CAR-T and NK Cell Therapy, offering groundbreaking solutions for hematological malignancies. With a focus on conditions like lymphoma, leukemia, and multiple myeloma, the hospital is dedicated to delivering highly specialized cancer treatment. They have successfully treated nearly 4,000 patients with CAR-T cell therapy, demonstrating a strong track record.
The hospital boasts one of the world’s most extensive CAR-T therapy portfolios, featuring nearly 30 CAR-T targets including CD7-CART, CD5-CART, and triple-target CART for CD19/CD22/CD20. These innovative therapies are crucial for patients with refractory and relapsed cancers, achieving remarkable success rates in both adult and pediatric populations. Additionally, the clinic enhances its comprehensive care with cutting-edge CAR-NK and UCART therapies, ensuring a broad range of advanced treatment options. Their multidisciplinary team works tirelessly to provide personalized care, combining expertise with compassionate support.
Unparalleled Expertise in Hematological Malignancy Treatment
Discover why Beijing Gobroad Boren Hospital is a top choice for advanced cancer therapies.
Choosing Beijing Gobroad Boren Hospital means entrusting your care to a facility with a proven track record of clinical excellence and a deep commitment to patient well-being. Our extensive experience in CAR-T therapy, with thousands of successful treatments, underscores our capability to handle complex cancer cases. We pride ourselves on pushing the boundaries of medical innovation to deliver superior outcomes. Our dedicated medical team works tirelessly to provide hope and healing to every individual.
Patients benefit from our advanced technology and personalized approach to cancer treatment, which are foundational to our care philosophy. We understand that each patient’s journey is unique, and we tailor our strategies to meet specific needs. This commitment to individualized care, combined with our world-class medical expertise, ensures that you receive the most effective and compassionate treatment possible. We are committed to supporting you every step of the way.
❝With over 4,000 patients treated to date, our clinical outcomes are a testament to the effectiveness of our cutting-edge therapies and the dedication of our highly skilled medical team.
State-of-the-Art Facilities and Cutting-Edge Technology for Oncology
Our core medical technologies include advanced CAR-T cell therapy and hematopoietic stem cell transplantation. These are used to effectively treat various hematologic malignancies such as leukemia, lymphoma, and multiple myeloma in both adults and children, as well as autoimmune diseases and some solid tumors. Our state-of-the-art facilities are equipped with the latest diagnostic and therapeutic tools. We have achieved excellent clinical outcomes due to our broad range of nearly 30 CAR-T targets, which are among the most comprehensive in the field, including CD7-CART, CD5-CART, CD19/CD22/CD20-triple target CART, CAR-NK, and UCART.
To date, our commitment to research and innovation is reflected in over 50 global academic papers published and more than 100 presentations at international academic conferences. This dedication ensures that our patients benefit from the most current and effective treatment protocols available. We continuously integrate new scientific discoveries into our practice. Our team is at the forefront of oncology research and development, striving to enhance patient care and treatment efficacy constantly.
Comprehensive and Innovative Cancer Treatment Services Available
Explore the advanced oncology procedures offered at Beijing Gobroad Boren Hospital.
⚕ CAR-T Cell Therapy for Cancer
CAR-T cell therapy is a pioneering treatment where a patient’s T cells are genetically engineered to recognize and attack cancer cells. This revolutionary therapy is particularly effective for refractory and relapsed hematological malignancies. Our hospital provides an extensive range of CAR-T targets, making it a leading choice globally for this specialized treatment. We continually advance our protocols to maximize patient safety and efficacy.
⚕ NK Cell Therapy for Cancer
NK Cell Therapy leverages the natural killer cells of the immune system to target and destroy cancer cells. This treatment offers a promising option for various cancer types, often with fewer side effects compared to traditional chemotherapy. Our program integrates advanced NK cell protocols to enhance immune response and improve patient outcomes. This therapy represents a significant step forward in personalized cancer care. It focuses on boosting the body’s natural defenses against disease.
⚕ Lymphoma Treatments
We provide personalized treatment plans based on the type and stage of lymphoma, ensuring each patient receives the most effective care tailored to their specific needs. Our comprehensive approach combines advanced therapies with supportive care. This strategy aims to improve remission rates and enhance overall quality of life. We focus on innovative and targeted solutions.
⚕ Leukemia Treatments
Our leukemia treatments are designed to target leukemia cells directly, minimizing side effects and significantly improving patient outcomes. We utilize the latest protocols, including CAR-T cell therapy, to achieve deep and durable remissions. Each treatment plan is customized to the patient’s specific type of leukemia. Our specialists work diligently to provide compassionate care and the best possible results.
⚕ Multiple Myeloma Treatments
Our hospital provides advanced therapies for multiple myeloma, including novel CAR-T cell treatments specifically designed to target the unique characteristics of myeloma cells. These cutting-edge approaches aim to achieve sustained remissions and improve the quality of life for patients. We are committed to offering the latest advancements in myeloma treatment, ensuring personalized and effective care. Our team continuously researches new methods to combat this complex disease.
Meet Our Board-Certified Oncologists & Hematologists in Beijing
Our expert team at Beijing Gobroad Boren Hospital includes leading oncologists and hematologists dedicated to innovative cancer care.
Dr. Yajing Zhang
Dr. Yajing Zhang is a leading expert in CAR-T cell therapy at Beijing Gobroad Boren Hospital, driven by a deep passion for oncology and extensive experience in hematological malignancies. Her role involves leveraging the latest CAR-T technologies to deliver highly targeted and effective treatments. Dr. Zhang specializes in providing personalized care, meticulously crafting treatment plans to suit each patient’s unique needs and circumstances, ensuring the highest standards of medical excellence.
Committed to advancing cancer treatment, Dr. Zhang continually pushes the boundaries of innovative approaches, significantly contributing to the hospital’s esteemed reputation in oncology. Her dedication not only enhances the therapeutic options available but also solidifies the hospital’s position at the forefront of cancer care, always prioritizing patient outcomes and well-being through advanced research and clinical practice.
Dr. Kai Hu
Dr. Kai Hu is a distinguished hematologist and oncologist renowned for his expertise in treating lymphoma and leukemia. His patient-centered approach ensures that each individual receives a comprehensive and compassionate care plan. Dr. Hu is committed to leveraging the latest research and clinical advancements. He integrates these into his practice to offer effective and innovative solutions for complex blood cancers. His dedication greatly benefits patients seeking cutting-edge care.
With years of specialized experience, Dr. Hu focuses on optimizing therapeutic outcomes while minimizing side effects. He actively participates in clinical trials and stays abreast of emerging treatments to provide the highest standard of care. Dr. Hu’s unwavering commitment to his patients’ health and recovery makes him a trusted figure in the field of hematologic oncology. He is a valuable asset to the medical team.
Dr. Shuangyou Liu
Dr. Shuangyou Liu is a highly respected hematologist and oncologist specializing in the diagnosis and treatment of multiple myeloma. With a deep understanding of this complex blood cancer, Dr. Liu develops individualized treatment strategies that incorporate the latest advancements in targeted therapies. His commitment to providing comprehensive care ensures patients receive personalized and effective solutions tailored to their unique condition. Dr. Liu emphasizes a holistic approach to patient management.
Recognized for his clinical acumen and compassionate demeanor, Dr. Liu works tirelessly to improve patient outcomes and quality of life. He actively engages in cutting-edge research and collaborates with international experts to integrate innovative techniques into his practice. His dedication to ongoing medical education ensures that his patients benefit from the most current and evidence-based treatments available. Dr. Liu is a vital part of our oncology team.
Dr. Jing Pan
Dr. Jing Pan is a visionary oncologist specializing in cancer immunotherapy, bringing advanced and personalized approaches to fight various solid tumors and hematological malignancies. She is at the forefront of integrating novel immunological treatments, including checkpoint inhibitors and cellular therapies, into patient care. Dr. Pan’s dedication ensures that patients benefit from the latest breakthroughs in harnessing the body’s immune system. Her work is vital for improving long-term outcomes for those with challenging cancers.
With a strong background in clinical research and a passion for personalized medicine, Dr. Pan designs treatment protocols that are highly effective and tailored to individual patient profiles. Her expertise in cancer immunotherapy makes her an invaluable asset to our medical team and a beacon of hope for patients seeking cutting-edge, immune-based solutions. She continuously seeks innovative strategies to combat cancer and enhance patient well-being.
Dr. Tong Wu
Dr. Tong Wu is a highly experienced hematologist and oncologist specializing in complex hematological cases, offering profound expertise in diagnosing and managing rare and challenging blood disorders. His meticulous approach to patient care combines advanced diagnostic techniques with tailored treatment protocols. Dr. Wu is dedicated to providing compassionate and effective solutions, particularly for patients who have exhausted standard treatment options. He actively works to improve quality of life for all his patients.
With a strong background in both clinical practice and academic research, Dr. Wu remains at the forefront of hematology, continuously integrating new discoveries into his therapeutic strategies. His commitment to comprehensive patient support and his profound knowledge in handling intricate cases make him a highly valued member of our oncology team. Dr. Wu is renowned for his ability to navigate the nuances of difficult hematological conditions with precision and care.
Inspiring Journeys: Real Patient Experiences with Advanced Cancer Care
Hear directly from individuals who have undergone successful cancer treatment at our hospital, sharing their paths to recovery.
Frequently Asked Questions About Cancer Treatment in China
What is CAR-T cell therapy and how does it work for cancer?
CAR-T cell therapy is an innovative treatment where a patient’s T cells are collected, genetically modified to express chimeric antigen receptors (CARs), and then infused back into the patient. These modified CAR-T cells are specifically designed to recognize and destroy cancer cells by targeting specific antigens on their surface. It is particularly effective for certain types of blood cancers, offering a personalized and highly potent immune response.
Which types of cancer are treated at Beijing Gobroad Boren Hospital?
Beijing Gobroad Boren Hospital specializes in treating hematological malignancies, including various forms of lymphoma, leukemia, and multiple myeloma. Our expertise extends to both adult and pediatric patients. We utilize advanced cellular therapies like CAR-T, NK Cell, and UCART to target these complex cancers, especially for refractory and relapsed cases. Our comprehensive programs ensure specialized care for a wide range of blood cancers.
What are the advantages of seeking cancer treatment in Beijing, China?
Beijing, China, offers several advantages for cancer treatment, including access to cutting-edge therapies like the extensive CAR-T cell therapy portfolio available at Beijing Gobroad Boren Hospital. The country is known for rapid advancements in medical technology, competitive treatment costs, and a strong emphasis on research and development in oncology. Patients benefit from highly skilled medical professionals and state-of-the-art facilities that often integrate traditional Chinese medicine with modern Western approaches.
How does NK Cell Therapy differ from CAR-T therapy?
While both NK Cell Therapy and CAR-T therapy harness the immune system to fight cancer, they differ in the type of immune cell used. CAR-T therapy genetically engineers T cells to recognize specific cancer antigens. NK Cell Therapy utilizes natural killer cells, which are inherent immune cells capable of identifying and destroying abnormal cells without prior sensitization. NK cells are generally associated with a lower risk of certain severe side effects, making them suitable for a broader range of patients.
What is the success rate of CAR-T cell therapy at Gobroad Boren Hospital?
Beijing Gobroad Boren Hospital has achieved remarkable success with its CAR-T cell therapy programs, having treated nearly 4,000 patients to date. The clinical outcomes demonstrate high efficacy, particularly for refractory and relapsed cancers, significantly improving patient prognosis. While specific individual success rates vary based on cancer type, stage, and patient factors, the hospital’s extensive experience and advanced protocols contribute to its leading position in effective CAR-T treatments.
Is personalized cancer treatment available at the hospital?
Yes, personalized cancer treatment is a cornerstone of care at Beijing Gobroad Boren Hospital. Our multidisciplinary team meticulously evaluates each patient’s unique condition, including cancer type, genetic markers, and medical history, to develop highly customized treatment plans. This tailored approach, often incorporating specific CAR-T targets or advanced NK cell protocols, ensures that therapy is optimized for individual needs, maximizing efficacy while minimizing adverse effects. Patients receive comprehensive support throughout their personalized treatment journey.
How do I schedule a consultation for cancer treatment?
Scheduling a consultation at Beijing Gobroad Boren Hospital through PlacidWay is a straightforward process. You can initiate contact via the “Request Your Free Quote Now” button on this profile, which will guide you through providing your medical information. Our patient care team will then connect you with the hospital’s specialists to arrange an initial assessment, review your case, and discuss potential treatment options. We aim to make your medical journey as seamless and stress-free as possible.
What support services are available for international patients?
Beijing Gobroad Boren Hospital, in conjunction with PlacidWay, offers extensive support services for international patients. These services typically include assistance with travel arrangements, accommodation, visa applications, and interpretation services to ensure a comfortable and smooth experience. Our dedicated patient coordinators are available to help navigate logistical aspects, allowing you to focus entirely on your treatment and recovery. We strive to provide a holistic and supportive environment for all our international guests.
Ready for a Consultation?
Contact PlacidWay to receive a customized treatment quote and coordinate your medical journey seamlessly.